 Connection
Edwin deZoeten to Interleukin-2
This is a "connection" page, showing publications Edwin deZoeten has written about Interleukin-2.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.309 |
|
|
|
-
de Zoeten EF, Carr-Brendel V, Cohen EP. Resistance to melanoma in mice immunized with semiallogeneic fibroblasts transfected with DNA from mouse melanoma cells. J Immunol. 1998 Mar 15; 160(6):2915-22.
Score: 0.130
-
de Zoeten EF, Li D, Cohen EP. Tumor immunity in mice immunized with fibroblasts transfected with tumor DNA. Adv Exp Med Biol. 2001; 495:393-401.
Score: 0.040
-
Glick RP, Lichtor T, de Zoeten E, Deshmukh P, Cohen EP. Prolongation of survival of mice with glioma treated with semiallogeneic fibroblasts secreting interleukin-2. Neurosurgery. 1999 Oct; 45(4):867-74.
Score: 0.036
-
de Zoeten E, Carr-Brendel V, Markovic D, Taylor-Papadimitriou J, Cohen EP. Treatment of breast cancer with fibroblasts transfected with DNA from breast cancer cells. J Immunol. 1999 Jun 01; 162(11):6934-41.
Score: 0.035
-
Fernandez IZ, Baxter RM, Garcia-Perez JE, Vendrame E, Ranganath T, Kong DS, Lundquist K, Nguyen T, Ogolla S, Black J, Galambos C, Gumbart JC, Dawany N, Kelsen JR, de Zoeten EF, Quinones R, Eissa H, Verneris MR, Sullivan KE, Rochford R, Blish CA, Kedl RM, Dutmer CM, Hsieh EWY. A novel human IL2RB mutation results in T and NK cell-driven immune dysregulation. J Exp Med. 2019 06 03; 216(6):1255-1267.
Score: 0.035
-
Sun T, Carr-Brendel V, De Zoeten EF, Cohen EP. Immunization with interleukin-2-secreting allogeneic cells transfected with DNA from mouse melanoma cells induces immune responses that prolong the lives of mice with melanoma. Cancer Gene Ther. 1998 Mar-Apr; 5(2):110-8.
Score: 0.032
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|